US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SDEV $7.48 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% TSLA $370.59 ▲+0.00%
FinancialContent

Articles published by Collegium Pharmaceutical, Inc.

< Previous 1 2 Next >
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Announces $50 Million Accelerated Share Repurchase Program
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Present New Real-World Data at PainConnect 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Paris Hilton Shares Her Experience with JORNAY PM and Launches New 'Embrace Your Sparkle' Campaign with Collegium to Empower the ADHD Community
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Report Fourth Quarter and Full-Year 2025 Financial Results on February 26, 2026
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Provides 2026 Financial Guidance and Business Update
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Announces the Closing of $980 Million Syndicated Credit Facility
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Participate in Upcoming Investor Conferences
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
News headline image
Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025
From Collegium Pharmaceutical, Inc.
Via GlobeNewswire
Tickers COLL
< Previous 1 2 Next >